↓ Skip to main content

Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age

Overview of attention for article published in Breast Cancer Research and Treatment, December 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#50 of 4,738)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
6 news outlets
blogs
1 blog
twitter
8 X users

Citations

dimensions_citation
100 Dimensions

Readers on

mendeley
121 Mendeley
Title
Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age
Published in
Breast Cancer Research and Treatment, December 2012
DOI 10.1007/s10549-012-2365-1
Pubmed ID
Authors

Christopher I. Li, Elisabeth F. Beaber, Mei-Tzu Chen Tang, Peggy L. Porter, Janet R. Daling, Kathleen E. Malone

Abstract

Aspects of reproductive history are among the most well-established breast cancer risk factors. However, relatively little is known about how they influence risk of different molecular subtypes of breast cancer, particularly among younger women. Using data from a population-based case-control study of women 20-44 years of age, we assessed the relationships between various reproductive factors and risk of estrogen receptor positive (ER+), triple-negative, and HER2-overexpressing breast cancers. Detailed reproductive histories were obtained through structured interviewer administered in-person questionnaires. Reproductive histories among control women (n = 941) were compared to those of ER+ cases (n = 781), triple-negative cases (n = 180), and HER2-overexpressing cases (n = 60) using polytomous logistic regression. Age at menarche, parity, and number of full-term pregnancies were similarly associated with risk of all three breast cancer subtypes. In contrast, age at first live birth, the interval between age at menarche and age at first birth, and breastfeeding were inversely associated with risk of triple-negative breast cancer (P values for trend 0.002, 0.006 and 0.018, respectively), but were not associated with risk of ER+ or HER2-overexpressing cancers. A strong inverse association between breastfeeding and risk of triple-negative breast cancer has now been consistently observed across numerous studies, and at present it is the most well-established protective factor for this aggressive and lethal form of breast cancer. Further studies clarifying the biological mechanisms underlying this relationship and confirming our results with respect to age at first birth and the interval between age at menarche and age at first birth are needed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Canada 1 <1%
Unknown 119 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 14%
Researcher 15 12%
Student > Bachelor 15 12%
Student > Ph. D. Student 14 12%
Student > Doctoral Student 6 5%
Other 21 17%
Unknown 33 27%
Readers by discipline Count As %
Medicine and Dentistry 44 36%
Biochemistry, Genetics and Molecular Biology 12 10%
Agricultural and Biological Sciences 9 7%
Nursing and Health Professions 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 10 8%
Unknown 36 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 70. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 October 2018.
All research outputs
#538,810
of 23,577,654 outputs
Outputs from Breast Cancer Research and Treatment
#50
of 4,738 outputs
Outputs of similar age
#3,904
of 282,625 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#3
of 63 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,738 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,625 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.